References
- Hsieh JC, Penn RD. Intrathecal baclofen in the treatment of adult spasticity. Neurosurg Focus 2006;21:E5.
- Coffey RJ, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg. 1993;78:226–32.
- Rushton DN. Intrathecal baclofen for control of spinal and supraspinal spasticity. In Barnes MP, Johnson GR, editors. Upper motor neurone syndrome and spasticity. Cambridge, England: Cambridge University Press; 2001. p. 24.
- Coffey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgley PM, et al. Abrupt withdrawal from intrathecal baclofen: Recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil. 2002;83:735–41.
- Kireyev D, Poh KK. Reversible electrocardiogram changes and cardiomyopathy secondary to baclofen withdrawal syndrome. Am Heart Hosp J. 2009;8:52–4.
- Pizon AF, LoVecchio F. Reversible cardiomyopathy complicating intrathecal baclofen withdrawal: A case report. J Med Toxicol. 2007;3:187–9.
- Huang J, Herscovici P, Oppenheimer, B. Reversible cardiomyopathy in a patient with intrathecal baclofen withdrawal. Am J Respir Crit Care Med. 2011;183:A3891.
- Ramaraj R, Movahed MR. Reverse or inverted takotsubo cardiomyopathy (reverse left ventricular apical ballooning syndrome) presents at a younger age compared with the mid or apical variant and is always associated with triggering stress. Congest Heart Fail. 2010;16:284–6.
- Mazzetti IA, Marcaccio MJ, Boutross-Tadross O, Salehian O, Demers C. The ace of spades: Reverse takotsubo cardiomyopathy in the context of angiographic embolization of recurrent metastatic serotonin-positive neuroendocrine tumour of the pancreas. Case Rep Med. 2013;79:3193–6.
- Christoph M, Ebner B, Stolte D, Ibrahim K, Kolschmann S, Strasser RH, et al. Broken heart syndrome: Takotsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor venlafaxine. Eur Neuropsychopharmacol. 2010;20:594–7.
- Levine M, Truitt CA, O’Connor AD. Cardiotoxicity and serotonin syndrome complicating a milnacipran overdose. J Med Toxicol. 2011;7:312–6.
- Mehta NK, Aurigemma G, Rafeq Z, Starobin O. Reverse takotsubo cardiomyopathy after an episode of serotonin syndrome. Tex Heart Inst J. 2011;38:568–72.
- Meythaler JM, Roper JF, Brunner RC. Cyproheptadine for intrathecal baclofen withdrawal. Arch Phys Med Rehabil. 2003; 84:638–42.
- Dvorak EM, Ketchum NC, McGuire JR. The underutilization of intrathecal baclofen in post stroke spasticity. Top Stroke Rehabil. 2011;18:195–202.